Home
Foley Hoag LLP
Tina Papagiannopoulos
Tina Papagiannopoulos
Foley Hoag LLP
FDA Shares Insights On Potential Pathway To Regulate CBD Products
06 Jun 2023 | United States
FDA Issues Safety Communication About Genetic Non-Invasive Prenatal Screening Tests
27 Apr 2022 | United States
FDA Issues Draft Guidance Recommending "Race And Ethnicity Diversity" Plans For Clinical Trial Sponsors
22 Apr 2022 | United States
Harmonization Is Key: FDA's Proposed Rule Seeks To Revamp Medical Device Quality System Regulation
01 Mar 2022 | United States
Next Up: Uniform Licensure Standards For Wholesalers And Third-Party Logistics Providers
15 Feb 2022 | United States
FDA Releases The Latest In A Series Of Draft Guidance Documents On Real World Data
07 Dec 2021 | United States
Public Health Agencies Release "Guiding Principles" For Good Machine Learning Practice
08 Nov 2021 | United States
FDA Updates Select Q&As On Biosimilar Regulation
24 Sep 2021 | United States
Caught In FDA's Crosshairs: Delta-8 THC Products Invite Increased Scrutiny
21 Sep 2021 | United States
USDA Seeks Comment On Cultured Meat And Poultry Labeling
09 Sep 2021 | United States
The Not So Weaved Web: The Fate Of CBD Products Is In FDA's Hands
23 Aug 2021 | United States
New Intended Use Rule Finalized
06 Aug 2021 | United States
President Signs Executive Order To Ensure Essential Medical Products Are Made In The USA
11 Aug 2020 | United States
FDA Issues New Guidance To Developers Of COVID-19 Drugs And Biological
03 Jun 2020 | United States
FDA Issues Guidance On Supply Interruptions And Discontinuance Notification Requirements For Emergency And Life Supporting Drugs
30 Apr 2020 | United States
FDA Develops Program To Expedite COVID-19 Drug Review
24 Apr 2020 | United States
FDA Issues Emergency Use Authorizations For Additional Medical Devices In Response To COVID-19
18 Apr 2020 | United States
Contact Details
Washington, DC
Email Website
Washington, DC
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.